Boehringer Ingelheim Has Two Years To Prepare CFC-Free Combivent
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA rejects a petition the firm had submitted in 2006 asking the agency exempt the COPD drug from a ban on ozone-depleting substances.